10don MSN
The 8 best forex brokers in the USA
Looking for a forex broker? These are some of the best in the USA right now.
MUMBAI: With the Reserve Bank drastically liberalizing the external commercial borrowing (ECB) norms, investment bankers are ...
Chart patterns are one of the most effective trading tools for a trader. They are pure price-action, and form on the basis of underlying buying and selling pressure. Chart patterns have a proven track ...
Fabrinet FN is riding multiple AI infrastructure buildouts that are increasingly running in parallel. That matters because it broadens the demand base, supports steadier utilization, and creates ...
The real danger of an appreciating naira is confusing excitement with endurance. A currency supported by production and exports has staying power. A currency supported mainly by interest rate ...
EIDO faces domestic policy uncertainty, MSCI reclassification risks, and credit outlook downgrades. Click here to find out why EIDO is a Sell.
Good morning, ladies and gentlemen, and welcome to Veolia Annual Results 2025 Conference Call with Estelle Brachlianoff, CEO; and Emmanuelle Menning, CFO; and also Daniel Tugues, Country Director of ...
Intuit INTU reported second-quarter fiscal 2026 non-GAAP earnings per share (EPS) of $4.15, which beat the Zacks Consensus Estimate of $3.66. The bottom line jumped 25% from the year-ago quarter.The ...
A SpiceJet flight to Leh returned to Delhi after an engine issue, with around 150 passengers safely disembarked, the airline said.
The viral “2028 Global Intelligence Crisis” report predicted a bleak future for India’s IT sector and global markets. But tech leaders and investors say the alarm is overblown.
AllAfrica on MSN
No bank? No problem - How Shuffle.com is quietly becoming West Africa's go-to crypto casino
In a region where over half of adults remained unbanked as recently as 2021 (World Bank Global Findex), where the naira has lost dramatic value in recent years, and where 60 million people bet daily, ...
BioSpectrum India on MSN
Ranbaxy results
Ranbaxy surpass 2012 guidance; Crosses Rs.120 Bn in Global sales Q4 CY 2012 Sales Rs.26,708 Mn CY 2012 Sales Rs.123 Bn, EBITDA Rs.18,227 Mn EBITDA margin 15%. Sales growth of 23% in Rupee termsRanbaxy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results